Catalyst Attempts to Block Rival Drug Already Approved
Catalyst tries to mitigate approval of Jacobus’ LEMS treatment drug.
Sara is a credited freelance writer, editor, contributor, and essayist, as well as a novelist and poet with nearly twenty years of experience. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She has an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling, graduating with a 4.2/4.0 GPA. She is also a member of Chi Sigma Iota and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her fifth book, PTSD: Healing from the Inside Out, was released in September 2019 and is available on Amazon. You can find her others books there, too, including Narcissistic Abuse: A Survival Guide, released in December 2017.
Catalyst tries to mitigate approval of Jacobus’ LEMS treatment drug.
The Department of Justice continues to crack down on medical personnel stealing opioids from hospitals.
Anti-corruption advocate Alexei Navalny is in an intensive care unit after being poisoned.
Charity distributes free smartphones to the homeless.
Study shows multifocal contact lenses are safe for children and may slow progression of nearsightedness.
Department of Labor investigation finds Boehringer’s female employees were being paid less than their male colleagues.
LA mayor issues order to shut off utilities at non-compliant house parties.
Coronavirus super-spreader event suggests individuals who’ve recovered are susceptible to reinfection unless they develop neutralizing antibodies.
Customers can now purchase marijuana in vending machines, limiting social contact during the pandemic.
Memo revealed during bankruptcy proceedings suggests Purdue’s charges should have been much worse years ago.